semaglutide and general anesthesia New therapeutic agents for type 2 diabetes: anaesthetic considerations. A narrative review Perioperative Considerations for Patients on

A 2025 meta-analysis of randomised controlled trials found no signal

Side effects vary by peptide: These may include fatigue, water retention, appetite changes, or tingling

Personalized Alternatives: When PlexusDx Compounded Therapy May Be Right for You Not everyone needs dual commercial medications to achieve weight loss and metabolic health

In patients with type 2 diabetes and established cardiovascular disease, semaglutide has been shown to reduce the risk of major adverse cardiovascular events (MACE) such as heart attack, stroke, or cardiovascular death

Stress and Stability: Applying the Anna Karenina Principle to Animal Microbiomes

Introducing prebiotic fiber too early in your GLP-1 protocol, before your body has adjusted to the medication, can intensify gastrointestinal side effects significantly